MOLECULAR TARGETING OF HER-2/NEU PROTEIN IS NOT RECOMMENDED AS AN ADJUVANT THERAPY IN ORAL SQUAMOUS CELL CARCINOMA AND ORAL LICHEN PLANUS

Molecular Targeting of Her-2/neu Protein Is Not Recommended as an Adjuvant Therapy in Oral Squamous Cell Carcinoma and Oral Lichen Planus

Purpose: Target therapy against molecular markers of EGFR family has been recently used in the treatment protocol of several diseases.However, the role of Her-2/neu in OSCC is a matter of controversy and more studies are required to clarify the role of Her-2/neu in OSCC.We aimed to investigate the role of Her-2/neu in the process of carcinogenesis

read more